'Self-sabotage' prevents immune protection against malaria

by Walter and Eliza Hall InstituteAustralian scientists have for the first time revealed how malaria parasites cause an inflammatory reaction that sabotages our body's ability to protect itse

Updated on: April 01,2024

'Self-sabotage' prevents immune protection against malaria

by Walter and Eliza Hall InstituteAustralian scientists have for the first time revealed how malaria parasites cause an inflammatory reaction that sabotages our body's ability to protect itse

Updated on:April 01,2024

A new device provides added protection against COVID-19 during endoscopic procedures

by Tohoku UniversityThe device. Credit: Hiroyuki EndoThe COVID-19 pandemic has thrown up unimaginable challenges for healthcare workers. Even simple outpatient procedures such as endoscopies can

Updated on: April 01,2024

A new device provides added protection against COVID-19 during endoscopic procedures

by Tohoku UniversityThe device. Credit: Hiroyuki EndoThe COVID-19 pandemic has thrown up unimaginable challenges for healthcare workers. Even simple outpatient procedures such as endoscopies can

Updated on:April 01,2024

Opinion: Full-body scans to look for hidden disease are a bad idea—here's why

by Adam Taylor,The ConversationCredit: Pixabay/CC0 Public DomainFor a not insubstantial fee, many private clinics in the UK offer full-body MRI scans to detect disease and abnormalities at the e

Updated on: September 11,2024

Opinion: Full-body scans to look for hidden disease are a bad idea—here's why

by Adam Taylor,The ConversationCredit: Pixabay/CC0 Public DomainFor a not insubstantial fee, many private clinics in the UK offer full-body MRI scans to detect disease and abnormalities at the e

Updated on:September 11,2024

COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

by Charité - Universitätsmedizin BerlinThe older a person with COVID-19 is, the higher the frequency of T-helper cells which react to the virus. However, fewer and fewer of these cells produce th

Updated on: April 10,2024

COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

by Charité - Universitätsmedizin BerlinThe older a person with COVID-19 is, the higher the frequency of T-helper cells which react to the virus. However, fewer and fewer of these cells produce th

Updated on:April 10,2024

Study explores characteristics associated with poor COVID-19 antibody response

by Melissa Rohman,Northwestern UniversityAnti-S1 IgG levels over time between first vaccine dose and serosurvey by socio-demographic and clinical correlates. Plot of predicted anti-S1 antibody l

Updated on: March 27,2024

Study explores characteristics associated with poor COVID-19 antibody response

by Melissa Rohman,Northwestern UniversityAnti-S1 IgG levels over time between first vaccine dose and serosurvey by socio-demographic and clinical correlates. Plot of predicted anti-S1 antibody l

Updated on:March 27,2024

Lives could be saved from tropical disease with new rapid test

by Wellcome Trust Sanger InstituteCredit: Karolina Grabowska from PexelsGlobally, more than half of patients die after infection with the neglected tropical disease, melioidosis, often before the

Updated on: March 20,2024

Lives could be saved from tropical disease with new rapid test

by Wellcome Trust Sanger InstituteCredit: Karolina Grabowska from PexelsGlobally, more than half of patients die after infection with the neglected tropical disease, melioidosis, often before the

Updated on:March 20,2024

India Endures a Scorching 52.9°C Heatwave

Updated on: June 05,2024

India Endures a Scorching 52.9°C Heatwave

Updated on:June 05,2024

Meningococcal disease on the rise in the US

by Deb Balzer,Mayo ClinicNeisseria meningitidisbacteria, responsible for causing meningococcal meningitis. Credit: CDCA rise in invasive serogroup Y meningococcal disease has prompted the

Updated on: April 30,2024

Meningococcal disease on the rise in the US

by Deb Balzer,Mayo ClinicNeisseria meningitidisbacteria, responsible for causing meningococcal meningitis. Credit: CDCA rise in invasive serogroup Y meningococcal disease has prompted the

Updated on:April 30,2024

How HIV research has reshaped modern medicine

If it wasn’t for the decades of HIV research, we would not have had the COVID-19 vaccines so rapidly.

Updated on: November 28,2024

How HIV research has reshaped modern medicine

If it wasn’t for the decades of HIV research, we would not have had the COVID-19 vaccines so rapidly.

Updated on:November 28,2024

MS patients face much greater risk of hospitalization, death from COVID-19, despite high rates of vaccination

by European Society of Clinical Microbiology and Infectious DiseasesCredit: Pixabay/CC0 Public DomainNew real-world research being presented at this year's European Congress of Clinical Microbiolo

Updated on: April 30,2024

MS patients face much greater risk of hospitalization, death from COVID-19, despite high rates of vaccination

by European Society of Clinical Microbiology and Infectious DiseasesCredit: Pixabay/CC0 Public DomainNew real-world research being presented at this year's European Congress of Clinical Microbiolo

Updated on:April 30,2024

What is eastern equine encephalitis? Two mosquito researchers explain what's behind the latest outbreaks

by Cameron Webb and Andrew van den Hurk,The ConversationBlue jays are an important host of eastern equine encephalitis virus in the United States. Credit:Mathew Schwartz/UnsplashHealth aut

Updated on: September 10,2024

What is eastern equine encephalitis? Two mosquito researchers explain what's behind the latest outbreaks

by Cameron Webb and Andrew van den Hurk,The ConversationBlue jays are an important host of eastern equine encephalitis virus in the United States. Credit:Mathew Schwartz/UnsplashHealth aut

Updated on:September 10,2024

Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science

Updated on: November 29,2024

Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science

Updated on:November 29,2024